Patents
Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
07/2013
07/30/2013US8497243 Methods and compositions useful in the treatment of mucositis
07/30/2013US8497093 Leafhopper ecdysone receptor nucleic acids, polypeptides, and uses thereof
07/30/2013US8497087 Method for producing target substance by fermentation
07/30/2013US8497075 Methods of identifying a modulator that inhibits the binding between Epstein-Barr virus induced receptor 2 and cholesterol derived ligands
07/30/2013US8497074 Granin proteins as markers of heart disease
07/30/2013US8497070 Angiogenin mutations and amyotrophic lateral sclerosis or motor neuron disease
07/30/2013US8496935 Immunosuppressive polypeptides and nucleic acids
07/30/2013US8496921 Consensus interferon variant and methods of suppressing viral activity
07/30/2013CA2744096C Biomarkers and targets for diagnosis, prognosis and management of prostate disease
07/30/2013CA2704083C Pigment epithelium-derived factor: characterization, genomic organization and sequence of the pedf gene
07/30/2013CA2691091C Fusion protein, macromolecule assembled from the fusion protein, and its use in the prevention or treatment of human papillomavirus related diseases
07/30/2013CA2654770C Increased lysine production by gene amplification
07/30/2013CA2611823C Conjugates having a degradable linkage and polymeric reagents useful in preparing such conjugates
07/30/2013CA2568201C Identification of ergothioneine transporter and therapeutic uses thereof
07/30/2013CA2561377C Mussel bioadhesive
07/30/2013CA2545693C Modification of protein glycosylation in methylotrophic yeast
07/30/2013CA2526128C Severe acute respiratory syndrome dna vaccine compositions and methods of use
07/30/2013CA2518944C Inhibitors of extracellular hsp90
07/30/2013CA2515335C Growth factor complexes and modulation of cell migration and growth
07/30/2013CA2513213C Albumin fusion proteins
07/30/2013CA2502668C Fully human antibody fab fragments with human interferon-gamma neutralizing activity
07/30/2013CA2480079C Antiangiogenic active immunotherapy
07/30/2013CA2476274C Common protein surface shapes and uses therefor
07/30/2013CA2425174C Human gene critical to fertility
07/30/2013CA2413754C Canine hepatocyte growth factor
07/25/2013WO2013110026A1 Compositions and methods relating to lyme disease
07/25/2013WO2013109904A1 Compositions, methods and kits for treatment of cancer and autoimmune diseases
07/25/2013WO2013109754A1 Plant transcription factors, promoters and uses thereof
07/25/2013WO2013109342A1 Method of treating diabetes using non-glycosylated apolipoprotein a-iv
07/25/2013WO2013108983A1 Ph-reactive high-density lipoprotein-like particle complex
07/25/2013WO2013108869A1 Therapeutic or prophylactic agent for cancer
07/25/2013WO2013108780A1 AMYLOID β-PROTEIN-SPECIFIC PRODUCTION-INHIBITING POLYPEPTIDE
07/25/2013WO2013108561A1 Marker peptide for determining risk of developing metabolic syndrome and use thereof
07/25/2013WO2013107905A1 Tools and methods for expression of membrane proteins
07/25/2013WO2013107791A1 Targeted mutant alpha-helical bundle cytokines
07/25/2013WO2013107633A1 Soluble immunoreactive treponema pallidum tpn47 antigens
07/25/2013WO2013107527A1 Novel genes and uses thereof for secondary metabolite production in plants
07/25/2013WO2013107526A2 Synthetic genes encoding peptide fragments of natural myelin proteins for induction of oral tolerance, dna fragment comprising these genes, means of obtaining these peptides in a microbial (bacterial) system and their medical application
07/25/2013WO2013107415A1 Cell-targeted magnetic nano-material and biomedical uses thereof
07/25/2013WO2013107290A1 A novel paramyxovirus and uses thereof
07/25/2013WO2013106909A1 Novel peptides and methods and uses thereof for preventing retinal disorders
07/25/2013WO2013072901A3 Compositions and methods for treating glioma
07/25/2013WO2013070256A3 Protease activated receptor-1 (par1) derived cytoprotective polypeptides and related methods
07/25/2013WO2012128786A3 Compositions and methods for separating, characterizing and administering soluble selenoglycoproteins
07/25/2013US20130191942 Transgenic Plants
07/25/2013US20130191933 Methods of treating pain and morphine tolerance via modulation of hedgehog signalling pathway
07/25/2013US20130190480 Oriented collagen/apatite material and method for producing oriented collagen/apatite material
07/25/2013US20130190476 Recombinantly expressed insulin polypeptides and uses thereof
07/25/2013US20130190407 Calcium receptor-active molecules
07/25/2013US20130190357 Compositions and methods for assessing and treating a precursor lesion and/or esophageal cancer
07/25/2013US20130190254 Polypeptides that bind membrane proteins
07/25/2013US20130190253 Glycosylation of Molecules
07/25/2013US20130190250 Polynucleotides Encoding Human Signal Peptide-Containing Proteins
07/25/2013US20130190247 Peptide antagonists of zonulin and methods for use of the same
07/25/2013US20130190242 Polymer-Von Willebrand Factor-Conjugates
07/25/2013US20130190240 Tumor growth controlling method targeting galactosylceramide expression factor-1
07/25/2013US20130190236 BMP-7 Variants with Reduced Immunogenicity
07/25/2013US20130190231 Peptide for suppressing and treating obesity
07/25/2013US20130190222 Concentrated aqueous silk fibroin solution and use thereof
07/25/2013US20130190221 Monomeric recombinant mhc molecules useful for manipulation of antigen-specific t-cells
07/25/2013US20130189776 Use of Molecular Chaperones for the Enhanced Production of Secreted, Recombinant Proteins in Mammalian Cells
07/25/2013US20130189733 Production of secreted proteins by filamentous fungi
07/25/2013US20130189715 Hemolysin and its Protein Fragments in Sero-Detection of Anaplasma Phagocytophilum
07/25/2013US20130189712 T2r, a novel family of taste receptors
07/25/2013US20130189697 IDENTIFICATION OF ISOLATED GENOMIC NUCLEOTIDE FRAGMENTS FROM THE p15 REGION OF CHROMOSOME 11 ENCODING HUMAN TUMOR SUPPRESSING SUBTRANSFERABLE CANDIDATE 4 (TSSC4) AND VARIANTS THEREOF
07/25/2013US20130189695 IDENTIFICATION OF ISOLATED GENOMIC NUCLEOTIDE FRAGMENTS FROM THE p15 REGION OF CHROMOSOME 11 ENCODING HUMAN RIBOSOMAL PROTEIN L26 (RIBO26) AND VARIANTS THEREOF
07/25/2013US20130189694 IDENTIFICATION OF ISOLATED GENOMIC NUCLEOTIDE FRAGMENTS FROM THE p15 REGION OF CHROMOSOME 11 ENCODING HUMAN TUMOR SUPPRESSING SUBTRANSFERABLE CANDIDATE 6 (TSSC6) AND VARIANTS THEREOF
07/25/2013US20130189693 IDENTIFICATION OF ISOLATED GENOMIC NUCLEOTIDE FRAGMENTS FROM THE p15 REGION OF CHROMOSOME 11 ENCODING HUMAN SMS3 AND VARIANTS THEREOF
07/25/2013US20130189691 IDENTIFICATION OF ISOLATED GENOMIC NUCLEOTIDE FRAGMENTS FROM THE p15 REGION OF CHROMOSOME 11 ENCODING HUMAN CLUSTER OF DIFFERENTIATION ANTIGEN 81 AND VARIANTS THEREOF
07/25/2013US20130189677 ABC terpenoid transporters and methods of using the same
07/25/2013US20130189371 Cross-linked bioactive hydrogel matrices
07/25/2013US20130189308 Expression of protective antigens in transgenic chloroplasts and the production of improved vaccines
07/25/2013US20130189306 Flavivirus Vaccines
07/25/2013US20130189300 Carrier molecule
07/25/2013US20130189298 Novel yeast strain and the application thereof
07/25/2013US20130189294 Rapid, efficient purification of hsv-specific t-lymphocytes and hsv antigens identified via same
07/25/2013US20130189289 Vaccine for treatment of tautopathy
07/25/2013US20130189284 Antibodies with t-cell receptor like specificity towards native complexes of mhc class ii and diabetes-associated autoantigenic peptides
07/25/2013US20130189280 Protein domains and uses therefor
07/25/2013US20130189273 Eg-vegf nucleic acids and polypeptides and methods of use
07/25/2013US20130189268 Colon and pancreas cancer specific antigens and antibodies
07/25/2013US20130189255 Fusions and conjugates of insulinotropic agents
07/25/2013US20130189254 Inhibition of AXL/GAS6 Signaling in the Treatment of Disease
07/25/2013US20130189245 Method for producing toxoids using alpha-dicarbonyl compounds
07/25/2013US20130189226 Recombinant human interferon-like proteins
07/25/2013US20130189219 N-terminally chemically modified protein compositions and methods
07/25/2013DE19742706B4 Lipocalinmuteine Lipocalin muteins
07/25/2013CA2861393A1 Tools and methods for expression of membrane proteins
07/25/2013CA2856187A1 Soluble immunoreactive treponema pallidum tpn47 antigens
07/24/2013EP2617831A2 Plants with altered root architecture, related constructs and methods involving genes encoding leucine rich repeat kinase (llrk) polypeptides and homologs thereof
07/24/2013EP2617733A1 Purification process
07/24/2013EP2617732A1 Tools and methods for expression of membrane proteins
07/24/2013EP2617731A1 Soluble immunoreactive Treponema pallidum TpN47 antigens
07/24/2013EP2617730A1 Lung cancer identification marker
07/24/2013EP2617431A2 Polypeptide inhibitors of HSP27 kinase and uses therefor
07/24/2013EP2617294A1 Expression of human milk proteins in transgenic plants
07/24/2013EP2616487A1 Serpin-finger fusion polypeptide
07/24/2013EP2616486A2 Factor viii variants having a decreased cellular uptake
07/24/2013EP2616485A2 Step-derived peptide for brain injury treatment
07/24/2013EP2616484A2 Screening method